[go: up one dir, main page]

CN114736212A - A kind of furo[3,2-b]indole derivative and its synthesis method and application - Google Patents

A kind of furo[3,2-b]indole derivative and its synthesis method and application Download PDF

Info

Publication number
CN114736212A
CN114736212A CN202210469120.0A CN202210469120A CN114736212A CN 114736212 A CN114736212 A CN 114736212A CN 202210469120 A CN202210469120 A CN 202210469120A CN 114736212 A CN114736212 A CN 114736212A
Authority
CN
China
Prior art keywords
furo
indole derivative
formula
indole
synthesizing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN202210469120.0A
Other languages
Chinese (zh)
Inventor
王程宇
马荣
刘明辉
管鹏程
姜雅坤
李飞岳
张汀慧
朱启萌
韩玉
孔令凯
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Linyi University
Original Assignee
Linyi University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Linyi University filed Critical Linyi University
Priority to CN202210469120.0A priority Critical patent/CN114736212A/en
Publication of CN114736212A publication Critical patent/CN114736212A/en
Pending legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D491/00Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04Ortho-condensed systems
    • C07D491/044Ortho-condensed systems with only one oxygen atom as ring hetero atom in the oxygen-containing ring
    • C07D491/048Ortho-condensed systems with only one oxygen atom as ring hetero atom in the oxygen-containing ring the oxygen-containing ring being five-membered
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/08Antiallergic agents
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Pulmonology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)

Abstract

The invention discloses a furo [3,2-b ] indole derivative and a synthesis method and application thereof, wherein the synthesis method comprises the following specific steps: taking a 2- (2-furyl) arylamine compound protected by tosyl as a raw material, adding an organic solvent, a catalyst, an oxidant and alkali in a protective atmosphere, and catalytically synthesizing to obtain the furo [3,2-b ] indole derivative shown in the formula (I). The preparation method realizes the coupling cyclization of NH and furan ring 3-position hydrogen under the catalysis of transition metal to obtain a target product. The raw materials are simple and easy to obtain, and the reaction conditions are mild. The invention also discloses application of the furo [3,2-b ] indole derivative shown in the formula (I) in preparing medicines for resisting allergy, tumors, pain and inflammation.

Description

一种呋喃并[3,2-b]吲哚衍生物及其合成方法和应用A kind of furo[3,2-b]indole derivative and its synthetic method and application

技术领域technical field

本发明属于有机化合物合成领域,具体涉及一种呋喃并[3,2-b]吲哚衍生物及其合成方法和应用The invention belongs to the field of organic compound synthesis, in particular to a furano[3,2-b]indole derivative, a synthesis method and application thereof

背景技术Background technique

呋喃并[3,2-b]吲哚骨架大量存在于具有生理活性的天然产物或药物分子中,呈现出不同的药物活性,譬如,具有抗过敏性、抗肿瘤活性、镇痛消炎的作用。因此,发展该类化合物合成方法研究,对于含呋喃并[3,2-b]吲哚骨架药物分子的合成具有重要的促进作用。另外,呋喃并[3,2-b]吲哚类衍生物还可以作为重要的有机合成单元,可在过渡金属催化下发生一系列的化学转化反应,构建吲哚啉-3-酮螺环、吲哚并杂环、吲哚-3-酮-2-烯等骨架分子。Furano[3,2-b]indole skeletons are abundantly present in natural products or drug molecules with physiological activity, showing different drug activities, such as antiallergic, antitumor activity, analgesic and anti-inflammatory effects. Therefore, the development of synthetic methods for these compounds has an important role in promoting the synthesis of furo[3,2-b]indole skeleton-containing drug molecules. In addition, furo[3,2-b]indole derivatives can also be used as important organic synthesis units, which can undergo a series of chemical transformation reactions under the catalysis of transition metals to construct indolin-3-one spiro rings, Indolo-heterocycle, indol-3-one-2-ene and other backbone molecules.

目前已知的合成该类骨架的方法还比较少,主要包括:(1)通过多步合成手段合成邻呋喃芳基叠氮化合物,在高温条件下分子内环化得到目标产物;(2)以邻呋喃硝基苯为原料,在烷氧基磷催化下分子内环化,得到呋喃并吲哚骨架;(3)通过多步合成手段构建邻(3-溴-2-呋喃基)芳胺为原料,通过分子内C-NUllmann偶联环化得到目标产物。但上述已报道的合成方法涉及的原料需要多步合成且收率不高,部分原料例如芳香叠氮化合物在实际操作过程中具有一定的危险性,很多反应条件较为苛刻反应温度高达160℃,目标产物收率不高,反应成本较高等缺点。因此,发展更加经济高效、操作简便的呋喃并[3,2-b]吲哚类衍生物的合成方法显得极为重要。Currently known methods for synthesizing such skeletons are relatively few, mainly including: (1) synthesizing o-furan aryl azide compounds by multi-step synthesis, and obtaining the target product by intramolecular cyclization under high temperature conditions; (2) using The o-furanyl nitrobenzene is used as the raw material, and the intramolecular cyclization is carried out under the catalysis of alkoxy phosphorous to obtain the furanoindole skeleton; (3) the o-(3-bromo-2-furyl) arylamine is constructed by a multi-step synthesis method as The starting material is cyclized by intramolecular C-NUllmann coupling to obtain the target product. But the raw materials involved in the above-mentioned reported synthetic methods need multi-step synthesis and the yield is not high, some raw materials such as aromatic azides have certain dangers in the actual operation process, and many reaction conditions are relatively harsh. The reaction temperature is up to 160 ° C, the target The product yield is not high, and the reaction cost is relatively high. Therefore, it is extremely important to develop more cost-effective and easy-to-operate synthetic methods for furo[3,2-b]indole derivatives.

发明内容SUMMARY OF THE INVENTION

本发明的目的是提供一种呋喃并[3,2-b]吲哚衍生物及其合成方法和应用,提供了一种原料简单易得、反应条件温和的合成方法。The purpose of the present invention is to provide a furano[3,2-b]indole derivative, a synthesis method and application thereof, and a synthesis method with simple and easily available raw materials and mild reaction conditions.

本发明提供了一种呋喃并[3,2-b]吲哚衍生物,其结构如式(I)所示:The present invention provides a furo[3,2-b]indole derivative, the structure of which is shown in formula (I):

Figure BDA0003625818780000021
Figure BDA0003625818780000021

式(I)中,In formula (I),

R为氢、C1-C20烷基或卤素。R is hydrogen, C1-C20 alkyl or halogen.

本发明还提供一种呋喃并[3,2-b]吲哚衍生物的合成方法,具体步骤为:以对甲苯磺酰基保护的2-(2-呋喃基)芳胺化合物为原料,在保护气氛下,加入有机溶剂、催化剂、氧化剂和碱,催化合成得到如式(I)所示的呋喃并[3,2-b]吲哚衍生物;The present invention also provides a method for synthesizing furo[3,2-b]indole derivatives. The specific steps are as follows: using a p-toluenesulfonyl-protected 2-(2-furanyl)arylamine compound as a raw material; Under the atmosphere, adding an organic solvent, a catalyst, an oxidizing agent and a base, the furo[3,2-b]indole derivative represented by the formula (I) is obtained by catalytic synthesis;

其反应过程如式(II)所示:Its reaction process is shown in formula (II):

Figure BDA0003625818780000022
Figure BDA0003625818780000022

式(II)中,R为氢、C1-C20烷基或卤素;所述催化剂为钯催化剂。In formula (II), R is hydrogen, C1-C20 alkyl or halogen; the catalyst is a palladium catalyst.

优选地,所述对甲苯磺酰基保护的2-(2-呋喃基)芳胺化合物:催化剂:氧化剂:碱的摩尔比为1:(0.1-0.5):(1-2):(0.5-2)。Preferably, the molar ratio of the p-toluenesulfonyl-protected 2-(2-furyl) arylamine compound: catalyst: oxidant: base is 1: (0.1-0.5): (1-2): (0.5-2 ).

优选地,所述对甲苯磺酰基保护的2-(2-呋喃基)芳胺化合物:催化剂:氧化剂:碱的摩尔比为1:0.1:2:0.5。Preferably, the molar ratio of the p-toluenesulfonyl-protected 2-(2-furyl) arylamine compound: catalyst: oxidant: base is 1:0.1:2:0.5.

优选地,所述钯催化剂选自PdCl2、Pd(TFA)2、Pd(OAc)2、PdCl2(PPh3)2、Pd(PPh3)4、Pd(dba)2和Pd2(dba)3中的一种或多种。Preferably, the palladium catalyst is selected from the group consisting of PdCl 2 , Pd(TFA) 2 , Pd(OAc) 2 , PdCl 2 (PPh 3 ) 2 , Pd(PPh 3 ) 4 , Pd(dba) 2 and Pd 2 (dba) one or more of 3 .

优选地,所述钯催化剂为PdCl2Preferably, the palladium catalyst is PdCl 2 .

优选地,所述氧化剂选自Cu(OAc)2、CuSO4、Cu(acac)2、六氟磷酸四乙氰铜、Cu(OTf)2、AgOAc和Ag2CO3中的一种或多种。Preferably, the oxidant is selected from one or more of Cu(OAc) 2 , CuSO 4 , Cu(acac) 2 , tetraethyl cyanide hexafluorophosphate, Cu(OTf) 2 , AgOAc and Ag 2 CO 3 .

优选地,所述氧化剂为Cu(OAc)2Preferably, the oxidant is Cu(OAc) 2 .

优选地,所述碱选自Cs2CO3、KOtBu、K2CO3、KOH、NEt3、DBU和K3PO4中的一种或多种。Preferably, the base is selected from one or more of Cs 2 CO 3 , KO t Bu, K 2 CO 3 , KOH, NEt 3 , DBU and K 3 PO 4 .

优选地,所述碱为Cs2CO3Preferably, the base is Cs 2 CO 3 .

优选地,所述有机溶剂选自1,2-二氯乙烷、乙腈、甲苯、1,4-二氧六环、二甲亚砜、N,N-二甲基甲酰胺、N,N-二甲基乙酰胺和四氢呋喃中的一种。Preferably, the organic solvent is selected from 1,2-dichloroethane, acetonitrile, toluene, 1,4-dioxane, dimethyl sulfoxide, N,N-dimethylformamide, N,N- One of dimethylacetamide and tetrahydrofuran.

优选地,所述反应的温度为50-120℃。Preferably, the temperature of the reaction is 50-120°C.

优选地,所述反应的时间为10-50h。Preferably, the reaction time is 10-50h.

本发明还提供了一种呋喃并[3,2-b]吲哚衍生物在制备抗过敏、抗肿瘤、镇痛消炎药物中的应用。The invention also provides the application of a furo[3,2-b]indole derivative in the preparation of anti-allergic, anti-tumor, analgesic and anti-inflammatory drugs.

在一个具体实施方案中,本发明制备方法中,在氮气下,以对甲苯磺酰基保护的2-(2-呋喃基)芳胺化合物为原料,在保护气氛下,以N,N-二甲基乙酰胺为有机溶剂,以PdCl2为催化剂,以Cu(OAc)2为氧化剂,以Cs2CO3为碱,在80℃下合成得到式(I)所示的呋喃并[3,2-b]吲哚衍生物,如以下反应式(III)所示:In a specific embodiment, in the preparation method of the present invention, under nitrogen, a p-toluenesulfonyl-protected 2-(2-furyl) arylamine compound is used as a raw material, and under a protective atmosphere, N,N-dimethyl acetamide as the organic solvent, PdCl 2 as the catalyst, Cu(OAc) 2 as the oxidant, and Cs 2 CO 3 as the base, at 80 °C, the furo[3,2- b] an indole derivative, as shown in the following reaction formula (III):

Figure BDA0003625818780000031
Figure BDA0003625818780000031

其中,R为氢、C1-C20烷基或卤素。Wherein, R is hydrogen, C1-C20 alkyl or halogen.

其中,所述对甲苯磺酰基保护的2-(2-呋喃基)芳胺化合物:PdCl2:Cu(OAc)2:Cs2CO3的摩尔比为1:0.1:2:0.5。Wherein, the molar ratio of the p-toluenesulfonyl-protected 2-(2-furyl) arylamine compound: PdCl 2 : Cu(OAc) 2 : Cs 2 CO 3 is 1:0.1:2:0.5.

其中,所述反应的时间为24-40h。Wherein, the time of the reaction is 24-40h.

本发明的有益效果是:本发明的一种呋喃并[3,2-b]吲哚衍生物的合成方法在钯催化剂的作用下实现NH与呋喃环3位的氢发生偶联环化,得到目标产物。反应条件温和且原料简单易得,具有普适性好、原子经济性高,后处理简单、收率良好(60%-80%),对环境友好等优点。本发明制备方法合成的呋喃并[3,2-b]吲哚衍生物中的呋喃并[3,2-b]吲哚骨架,是许多天然产物和药物分子中的重要结构单元,且大多具有较强的生物活性,能够进一步发生后续化学转化反应,在药物合成方面具有重大研究价值。The beneficial effects of the present invention are as follows: the method for synthesizing a furano[3,2-b]indole derivative of the present invention realizes the coupling cyclization of NH and the hydrogen at the 3-position of the furan ring under the action of a palladium catalyst to obtain target product. The reaction conditions are mild, the raw materials are simple and easy to obtain, and it has the advantages of good universality, high atom economy, simple post-processing, good yield (60%-80%), and environmental friendliness. The furo[3,2-b]indole skeleton in the furo[3,2-b]indole derivatives synthesized by the preparation method of the present invention is an important structural unit in many natural products and drug molecules, and most of them have It has strong biological activity and can further undergo subsequent chemical transformation reactions, and has great research value in drug synthesis.

具体实施方式Detailed ways

为了使本发明所解决的技术问题、技术方案及有益效果更加清楚明白,以下结合实施例,对本发明进行进一步的详细说明。应当理解,此处所描述的具体实施例仅仅用以解释本发明,并不用于限定本发明。在不背离发明构思的精神和范围下,本领域技术人员能够想到的变化和优点都被包括在本发明中,并且以所附的权利要求书为保护范围。实施本发明的过程、条件、试剂、实验方法等,除以下专门提及的内容之外,均为本领域的普遍知识和公知常识,本发明没有特别限制内容。In order to make the technical problems, technical solutions and beneficial effects solved by the present invention clearer, the present invention will be further described in detail below with reference to the embodiments. It should be understood that the specific embodiments described herein are only used to explain the present invention, but not to limit the present invention. Variations and advantages that can occur to those skilled in the art without departing from the spirit and scope of the inventive concept are included in the present invention, and the appended claims are the scope of protection. The process, conditions, reagents, experimental methods, etc. for implementing the present invention, except for the contents specifically mentioned below, are all common knowledge and common knowledge in the field, and the present invention has no special limited contents.

实施例1:4-Ts呋喃并[3,2-b]吲哚化合物(IA)合成Example 1: Synthesis of 4-Ts furo[3,2-b]indole compound (IA)

Figure BDA0003625818780000041
Figure BDA0003625818780000041

在氮气氛围下,向反应管中,加入Ts(对甲苯磺酰基)保护的邻呋喃芳胺化合物0.3mmol、N,N-二甲基乙酰胺6mL、二氯化钯0.03mmol、无水醋酸铜0.6mmol、碳酸铯0.15mmol。在80℃反应24小时,TLC检测反应结束后,然后冷却至室温,得到目标产物式(IA),黄色固体,分离收率75%。MP 128-131℃。Under a nitrogen atmosphere, 0.3 mmol of Ts (p-toluenesulfonyl) protected o-furan arylamine compound, 6 mL of N,N-dimethylacetamide, 0.03 mmol of palladium dichloride, and anhydrous copper acetate were added to the reaction tube. 0.6 mmol, 0.15 mmol of cesium carbonate. The reaction was carried out at 80° C. for 24 hours, and after TLC detection was completed, the reaction was cooled to room temperature to obtain the target product of formula (IA), a yellow solid, and the isolated yield was 75%. MP 128-131°C.

产物核磁数据:1H NMR(CDCl3,500MHz):δ2.27(s,3H),7.01(s,1H),7.12(d,J=5.0Hz,2H),7.26-7.28(m,2H),7.53-7.56(m,2H),7.67(d,J=5.0Hz,2H),8.12-8.14(m,1H)。13C NMR(CDCl3,125MHz):δ21.46,102.50,115.34,116.68,118.83,124.02,126.67,129.65,130.23,134.35,139.15,144.44,144.93,146.42。Product NMR data: 1 H NMR (CDCl 3 , 500MHz): δ 2.27(s, 3H), 7.01(s, 1H), 7.12(d, J=5.0Hz, 2H), 7.26-7.28(m, 2H) , 7.53-7.56 (m, 2H), 7.67 (d, J=5.0Hz, 2H), 8.12-8.14 (m, 1H). 13 C NMR (CDCl 3 , 125MHz): δ 21.46, 102.50, 115.34, 116.68, 118.83, 124.02, 126.67, 129.65, 130.23, 134.35, 139.15, 144.44, 144.93, 146.42.

高分辨率质谱数据:HRMS(ESI,m/z)calcd.for C17H14NO3S[M+H]+calc.:312.0694;found:312.0698。High resolution mass spectral data: HRMS (ESI, m/z) calcd. for C17H14NO3S [ M +H] + calc.: 312.0694 ; found: 312.0698.

实施例2:6-氯-4-Ts呋喃并[3,2-b]吲哚化合物(IB)合成Example 2: Synthesis of 6-chloro-4-Ts furo[3,2-b]indole compound (IB)

Figure BDA0003625818780000051
Figure BDA0003625818780000051

在氮气氛围下,向反应管中,加入Ts保护的2-呋喃-5-氯芳胺化合物0.3mmol、N,N-二甲基乙酰胺6mL、二氯化钯0.03mmol、无水醋酸铜0.6mmol、碳酸铯0.15mmol。在80℃反应24小时,TLC检测反应结束后,然后冷却至室温,得到目标产物式(IB),棕色固体,分离收率70%。MP 114-116℃。Under a nitrogen atmosphere, 0.3 mmol of Ts-protected 2-furan-5-chloroarylamine compound, 6 mL of N,N-dimethylacetamide, 0.03 mmol of palladium dichloride, and 0.6 mL of anhydrous copper acetate were added to the reaction tube. mmol, cesium carbonate 0.15mmol. The reaction was carried out at 80° C. for 24 hours, and after TLC detection was completed, the reaction was cooled to room temperature to obtain the target product of formula (IB) as a brown solid with an isolation yield of 70%. MP 114-116°C.

产物核磁数据:1H NMR(CDCl3,500MHz):δ2.31(s,3H),7.00(d,J=2.0Hz,1H),7.17(d,J=8.5Hz,2H),7.25(dd,J=8.5,2.0Hz,1H),7.47(d,J=8.5Hz,1H),7.54(d,J=2.0Hz,1H),7.69-7.71(m,2H),8.15(d,J=2.0Hz,1H)。13C NMR(CDCl3,125MHz):δ21.54,102.47,115.54,117.23,117.29,124.56,126.71,129.83,129.87,130.76,134.20,139.31,143.64,145.31,146.81。Product NMR data: 1 H NMR (CDCl 3 , 500MHz): δ 2.31 (s, 3H), 7.00 (d, J=2.0 Hz, 1H), 7.17 (d, J=8.5 Hz, 2H), 7.25 (dd ,J=8.5,2.0Hz,1H),7.47(d,J=8.5Hz,1H),7.54(d,J=2.0Hz,1H),7.69-7.71(m,2H),8.15(d,J= 2.0Hz, 1H). 13 C NMR (CDCl 3 , 125MHz): δ 21.54, 102.47, 115.54, 117.23, 117.29, 124.56, 126.71, 129.83, 129.87, 130.76, 134.20, 139.31, 143.64, 145.31, 146.81.

高分辨率质谱数据:HRMS(ESI,m/z)calcd.for C17H13ClNO3S[M+H]+calc.:346.0305;found:346.0310。High resolution mass spectral data: HRMS (ESI, m/z) calcd. for C17H13ClNO3S [ M +H]+calc.: 346.0305 ; found: 346.0310.

实施例3:6-甲基-4-Ts呋喃并[3,2-b]吲哚化合物(IC)合成Example 3: Synthesis of 6-methyl-4-Ts furo[3,2-b]indole compound (IC)

Figure BDA0003625818780000052
Figure BDA0003625818780000052

在氮气氛围下,向反应管中,加入Ts保护的5-甲基-2-呋喃芳胺化合物0.3mmol、N,N-二甲基乙酰胺6mL、二氯化钯0.03mmol、无水醋酸铜0.6mmol、碳酸铯0.15mmol。在80℃反应24小时,TLC检测反应结束后,然后冷却至室温,得到目标产物式(IC),黄色固体,分离收率72%。MP 135-136℃。Under nitrogen atmosphere, into the reaction tube, add 0.3 mmol of Ts-protected 5-methyl-2-furanarylamine compound, 6 mL of N,N-dimethylacetamide, 0.03 mmol of palladium dichloride, and anhydrous copper acetate 0.6 mmol, 0.15 mmol of cesium carbonate. The reaction was carried out at 80° C. for 24 hours, and after TLC detection was completed, the reaction was cooled to room temperature to obtain the target product of formula (IC) as a yellow solid, and the isolated yield was 72%. MP 135-136°C.

产物核磁数据:1H NMR(CDCl3,500MHz):δ2.27(s,3H),2.48(s,3H),6.98(d,J=2.5Hz,1H),7.08(d,J=7.5Hz,1H),7.13(d,J=8.0Hz,2H),7.43(d,J=8.0Hz,1H),7.49(d,J=2.0Hz,1H),7.68(d,J=8.5Hz,2H),7.94(s,1H)。13C NMR(CDCl3,125MHz):δ21.47,21.94,102.57,115.60,116.27,116.72,125.32,126.64,129.63,129.65,134.26,134.46,139.65,144.59,144.83,145.84。Product NMR data: 1 H NMR (CDCl 3 , 500MHz): δ 2.27(s, 3H), 2.48(s, 3H), 6.98(d, J=2.5Hz, 1H), 7.08(d, J=7.5Hz) ,1H),7.13(d,J=8.0Hz,2H),7.43(d,J=8.0Hz,1H),7.49(d,J=2.0Hz,1H),7.68(d,J=8.5Hz,2H ), 7.94(s, 1H). 13 C NMR (CDCl 3 , 125MHz): δ 21.47, 21.94, 102.57, 115.60, 116.27, 116.72, 125.32, 126.64, 129.63, 129.65, 134.26, 134.46, 139.65, 144.59, 144.83, 145.

高分辨率质谱数据:HRMS(ESI,m/z)calcd.for C18H16NO3S[M+H]+calc.:326.0851;found:326.0855。High resolution mass spectral data: HRMS (ESI, m/z) calcd. for C18H16NO3S [ M +H]+calc.: 326.0851 ; found: 326.0855.

实施例4:7-溴-4-Ts呋喃并[3,2-b]吲哚化合物(ID)合成Example 4: Synthesis of 7-bromo-4-Ts furo[3,2-b]indole compound (ID)

Figure BDA0003625818780000061
Figure BDA0003625818780000061

在氮气氛围下,向反应管中,加入Ts保护的2-呋喃-4-溴芳胺化合物0.3mmol、N,N-二甲基乙酰胺6mL、二氯化钯0.03mmol、无水醋酸铜0.6mmol、碳酸铯0.15mmol。在80℃反应24小时,TLC检测反应结束后,然后冷却至室温,得到目标产物式(ID),黄色液体,分离收率60%。Under a nitrogen atmosphere, 0.3 mmol of Ts-protected 2-furan-4-bromoarylamine compound, 6 mL of N,N-dimethylacetamide, 0.03 mmol of palladium dichloride, and 0.6 mL of anhydrous copper acetate were added to the reaction tube. mmol, cesium carbonate 0.15mmol. The reaction was carried out at 80° C. for 24 hours. After the reaction was detected by TLC, the reaction was cooled to room temperature to obtain the target product of formula (ID) as a yellow liquid with a separation yield of 60%.

产物核磁数据:1H NMR(CDCl3,500MHz):δ2.31(s,3H),7.00 -7.01(m,1H),7.16(d,J=8.0Hz,2H),7.37-7.39(m,1H),7.55-7.56(m,1H),7.66-7.70(m,3H),7.99(d,J=8.5Hz,1H)。13C NMR(CDCl3,125MHz):δ21.54,102.47,116.68,117.61,119.56,120.14,126.67,126.75,129.81,131.45,134.11,137.77,143.03,145.29,147.26。Product NMR data: 1 H NMR (CDCl 3 , 500MHz): δ2.31(s, 3H), 7.00-7.01(m, 1H), 7.16(d, J=8.0Hz, 2H), 7.37-7.39(m, 1H), 7.55-7.56 (m, 1H), 7.66-7.70 (m, 3H), 7.99 (d, J=8.5Hz, 1H). 13 C NMR (CDCl 3 , 125MHz): δ 21.54, 102.47, 116.68, 117.61, 119.56, 120.14, 126.67, 126.75, 129.81, 131.45, 134.11, 137.77, 143.03, 145.29, 147.26.

高分辨率质谱数据:HRMS(ESI,m/z)calcd.for C17H13BrNO3S[M+H]+calc.:389.9800;found:389.9805。High resolution mass spectral data: HRMS (ESI, m/z) calcd. for C17H13BrNO3S [ M +H]+calc.: 389.9800 ; found: 389.9805.

实施例5:7-氟-4-Ts呋喃并[3,2-b]吲哚化合物(IE)合成Example 5: Synthesis of 7-fluoro-4-Ts furo[3,2-b]indole compound (IE)

Figure BDA0003625818780000062
Figure BDA0003625818780000062

在氮气氛围下,向反应管中,加入Ts保护的2-呋喃-4-氟芳胺化合物0.3mmol、N,N-二甲基乙酰胺6mL、二氯化钯0.03mmol、无水醋酸铜0.6mmol、碳酸铯0.15mmol。在80℃反应24小时,TLC检测反应结束后,然后冷却至室温,得到目标产物式(IE),棕色固体,分离收率67%。MP 114-116℃。Under a nitrogen atmosphere, 0.3 mmol of Ts-protected 2-furan-4-fluoroarylamine compound, 6 mL of N,N-dimethylacetamide, 0.03 mmol of palladium dichloride, and 0.6 mL of anhydrous copper acetate were added to the reaction tube. mmol, cesium carbonate 0.15mmol. The reaction was carried out at 80° C. for 24 hours. After TLC detection was completed, the reaction was cooled to room temperature to obtain the target product of formula (IE) as a brown solid with an isolated yield of 67%. MP 114-116°C.

产物核磁数据:1H NMR(CDCl3,500MHz):δ2.29(s,3H),6.97-7.02(m,2H),7.14(d,J=8.0Hz,2H),7.21(dd,J=8.25,3.0Hz,1H),7.55(d,J=2.0Hz,1H),7.66(d,J=8.5Hz,2H),8.07(dd,J=9.3,4.5Hz,1H)。13C NMR(CDCl3,125MHz):δ21.51,102.60,103.07(d,J=25.9Hz),111.47(d,J=24.9Hz),116.48(d,J=9.6Hz),119.60(d,J=10.9Hz),126.67,129.73,131.94,134.08,135.37,143.85(d,J=2.5Hz),145.16,147.12,159.95(d,J=240.3Hz)。Product NMR data: 1 H NMR (CDCl 3 , 500MHz): δ 2.29 (s, 3H), 6.97-7.02 (m, 2H), 7.14 (d, J=8.0 Hz, 2H), 7.21 (dd, J= 8.25, 3.0Hz, 1H), 7.55 (d, J=2.0Hz, 1H), 7.66 (d, J=8.5Hz, 2H), 8.07 (dd, J=9.3, 4.5Hz, 1H). 13 C NMR (CDCl 3 , 125MHz): δ 21.51, 102.60, 103.07 (d, J=25.9 Hz), 111.47 (d, J=24.9 Hz), 116.48 (d, J=9.6 Hz), 119.60 (d, J= 10.9Hz), 126.67, 129.73, 131.94, 134.08, 135.37, 143.85 (d, J=2.5Hz), 145.16, 147.12, 159.95 (d, J=240.3Hz).

高分辨率质谱数据:HRMS(ESI,m/z)calcd.for C17H13FNO3S[M+H]+calc.:330.0600;found:330.0609。High resolution mass spectral data: HRMS (ESI, m/z) calcd. for C17H13FNO3S [ M +H]+calc.: 330.0600 ; found: 330.0609.

实施例6:7-甲基-4-Ts呋喃并[3,2-b]吲哚化合物(IF)合成Example 6: 7-Methyl-4-Ts furo[3,2-b]indole compound (IF) synthesis

Figure BDA0003625818780000071
Figure BDA0003625818780000071

在氮气氛围下,向反应管中,加入Ts保护的4-甲基-2-呋喃芳胺化合物0.3mmol、N,N-二甲基乙酰胺6mL、二氯化钯0.03mmol、无水醋酸铜0.6mmol、碳酸铯0.15mmol。在80℃反应24小时,TLC检测反应结束后,然后冷却至室温,得到目标产物式(IF),棕色固体,棕色液体,分离收率69%。Under nitrogen atmosphere, into the reaction tube, add 0.3 mmol of Ts-protected 4-methyl-2-furanarylamine compound, 6 mL of N,N-dimethylacetamide, 0.03 mmol of palladium dichloride, and anhydrous copper acetate 0.6 mmol, 0.15 mmol of cesium carbonate. The reaction was carried out at 80° C. for 24 hours. After TLC detection was completed, the reaction was cooled to room temperature to obtain the target product of formula (IF) as a brown solid and a brown liquid, and the isolated yield was 69%.

产物核磁数据:1H NMR(CDCl3,500MHz):δ2.26(s,3H),2.40(s,3H),6.98(d,J=2.0Hz,1H),7.08-7.12(m,3H),7.34(bs,1H),7.51(d,J=2.0Hz,1H),7.65-7.67(m,2H),7.99(d,J=8.5Hz,1H)。13C NMR(CDCl3,125MHz):δ21.30,21.46,102.55,115.09,116.78,119.06,125.26,126.66,129.60,130.36,133.88,134.31,137.48,144.46,144.79,146.25。Product NMR data: 1 H NMR (CDCl 3 , 500MHz): δ2.26(s, 3H), 2.40(s, 3H), 6.98(d, J=2.0Hz, 1H), 7.08-7.12(m, 3H) , 7.34 (bs, 1H), 7.51 (d, J=2.0Hz, 1H), 7.65-7.67 (m, 2H), 7.99 (d, J=8.5Hz, 1H). 13 C NMR (CDCl 3 , 125MHz): δ 21.30, 21.46, 102.55, 115.09, 116.78, 119.06, 125.26, 126.66, 129.60, 130.36, 133.88, 134.31, 137.48, 144.25, 144.79, 146.

高分辨率质谱数据:HRMS(ESI,m/z)calcd.for C18H16NO3S[M+H]+calc.:326.0851;found:326.0855。High resolution mass spectral data: HRMS (ESI, m/z) calcd. for C18H16NO3S [ M +H] + calc.: 326.0851 ; found: 326.0855.

实施例7:6-Ts苯丙呋喃并[3,2-b]吲哚化合物(IG)合成Example 7: Synthesis of 6-Ts phenylpropylfuro[3,2-b]indole compound (IG)

Figure BDA0003625818780000081
Figure BDA0003625818780000081

在氮气氛围下,向反应管中,加入Ts保护的2-苯并呋喃芳胺化合物0.3mmol、N,N-二甲基乙酰胺6mL、二氯化钯0.03mmol、无水醋酸铜0.6mmol、碳酸铯0.15mmol。在80℃反应24小时,TLC检测反应结束后,然后冷却至室温,得到目标产物式(IG),棕色固体,分离收率75%。MP 174-176℃。Under nitrogen atmosphere, into the reaction tube, add 0.3 mmol of Ts-protected 2-benzofuran arylamine compound, 6 mL of N,N-dimethylacetamide, 0.03 mmol of palladium dichloride, 0.6 mmol of anhydrous copper acetate, Cesium carbonate 0.15mmol. The reaction was carried out at 80° C. for 24 hours. After the reaction was detected by TLC, the reaction was cooled to room temperature to obtain the target product of formula (IG) as a brown solid with an isolation yield of 75%. MP 174-176°C.

产物核磁数据:1H NMR(CDCl3,400MHz):δ2.23(s,3H),7.05(d,J=8.0Hz,2H),7.33-7.44(m,4H),7.59-7.61(m,1H),7.64-7.69(m,3H),8.28(d,J=8.0Hz,1H),8.39-8.41(m,1H)。13C NMR(CDCl3,100MHz):δ21.46,112.57,115.77,117.53,118.52,119.24,120.58,123.91,124.39,124.57,124.93,125.39,126.77,129.73,134.20,139.49,144.94,146.67,159.26。Product NMR data: 1 H NMR (CDCl 3 , 400MHz): δ2.23(s, 3H), 7.05(d, J=8.0Hz, 2H), 7.33-7.44(m, 4H), 7.59-7.61(m, 1H), 7.64-7.69 (m, 3H), 8.28 (d, J=8.0Hz, 1H), 8.39-8.41 (m, 1H). 13 C NMR(CDCl 3 ,100MHz):δ21.46,112.57,115.77,117.53,118.52,119.24,120.58,123.91,124.39,124.57,124.93,125.39,126.77,129.73,134.20,139.49,144.94,146.67,159.26。

高分辨率质谱数据:HRMS(ESI,m/z)calcd.for C21H16NO3S[M+H]+calc.:362.0851;found:362.0859。High resolution mass spectral data: HRMS (ESI, m/z) calcd. for C21H16NO3S [ M +H] + calc.: 362.0851 ; found: 362.0859.

以上所述仅为本发明的较佳实施例而已,并不用以限制本发明,凡在本发明的精神和原则之内所作的任何修改、等同替换和改进等,均应包含在本发明的保护范围之内。The above descriptions are only preferred embodiments of the present invention and are not intended to limit the present invention. Any modifications, equivalent replacements and improvements made within the spirit and principles of the present invention shall be included in the protection of the present invention. within the range.

Claims (10)

1. A furo [3,2-b ] indole derivative is characterized by having a structure shown in formula (I):
Figure FDA0003625818770000011
in the formula (I), the compound is shown in the specification,
r is hydrogen, C1-C20 alkyl or halogen.
2. A synthetic method of furo [3,2-b ] indole derivatives shown in formula (I) is characterized by comprising the following specific steps:
taking a 2- (2-furyl) arylamine compound protected by tosyl as a raw material, adding an organic solvent, a catalyst, an oxidant and alkali in a protective atmosphere, and catalytically synthesizing to obtain a furo [3,2-b ] indole derivative shown in a formula (I);
the reaction process is shown as the formula (II):
Figure FDA0003625818770000012
in the formula (II), R is hydrogen, C1-C20 alkyl or halogen; the catalyst is a palladium catalyst.
3. The method for synthesizing a furo [3,2-b ] indole derivative according to claim 2, wherein the p-toluenesulfonyl protected 2- (2-furyl) arylamine compound: catalyst: oxidizing agent: the molar ratio of the alkali is 1: (0.1-0.5): (1-2): (0.5-2).
4. A furo [3,2-b ] according to claim 2]The synthesis method of the indole derivative is characterized in that the palladium catalyst is selected from PdCl2、Pd(TFA)2、Pd(OAc)2、PdCl2(PPh3)2、Pd(PPh3)4、Pd(dba)2And Pd2(dba)3One or more of (a).
5. A furo [3,2-b ] according to claim 2]The synthesis method of indole derivatives is characterized in that the oxidant is selected from Cu (OAc)2、CuSO4、Cu(acac)2Copper hexachloro-tetra-cyanide, Cu (OTf)2AgOAc and Ag2CO3One or more of (a).
6. A furo [3,2-b ] according to claim 2]A process for the synthesis of indole derivatives, characterized in that the base is selected from Cs2CO3、KOtBu、K2CO3、KOH、NEt3DBU and K3PO4One or more of (a).
7. The method for synthesizing furo [3,2-b ] indole derivative according to claim 2, wherein the organic solvent is one selected from 1, 2-dichloroethane, acetonitrile, toluene, 1, 4-dioxane, dimethyl sulfoxide, N-dimethylformamide, N-dimethylacetamide and tetrahydrofuran.
8. The method for synthesizing furo [3,2-b ] indole derivative according to claim 2, wherein the reaction temperature is 50-120 ℃.
9. The method for synthesizing furo [3,2-b ] indole derivative according to claim 2, wherein the reaction time is 10-50 h.
10. Use of the furo [3,2-b ] indole derivative according to claim 1 for preparing anti-allergic, anti-tumor, analgesic and anti-inflammatory drugs.
CN202210469120.0A 2022-04-29 2022-04-29 A kind of furo[3,2-b]indole derivative and its synthesis method and application Pending CN114736212A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN202210469120.0A CN114736212A (en) 2022-04-29 2022-04-29 A kind of furo[3,2-b]indole derivative and its synthesis method and application

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN202210469120.0A CN114736212A (en) 2022-04-29 2022-04-29 A kind of furo[3,2-b]indole derivative and its synthesis method and application

Publications (1)

Publication Number Publication Date
CN114736212A true CN114736212A (en) 2022-07-12

Family

ID=82285372

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202210469120.0A Pending CN114736212A (en) 2022-04-29 2022-04-29 A kind of furo[3,2-b]indole derivative and its synthesis method and application

Country Status (1)

Country Link
CN (1) CN114736212A (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN115124535A (en) * 2022-06-16 2022-09-30 中南民族大学 A kind of fused ring indole compound and its preparation method and application

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005000804A2 (en) * 2003-06-05 2005-01-06 Merck & Co., Inc. Substituted indoles and a process for preparing substituted indoles
CN109096293A (en) * 2018-08-28 2018-12-28 中节能万润股份有限公司 Preparation method of the one kind containing the benzofuran simultaneously alcohol compound of [2,3-b] pyridine structure
CN110964007A (en) * 2018-09-30 2020-04-07 江苏三月光电科技有限公司 Compound with quinolinone derivative as core and application of compound in organic electroluminescent device
CN111303171A (en) * 2020-03-27 2020-06-19 华中科技大学 A kind of benzofuranoindole compound, its preparation and application

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005000804A2 (en) * 2003-06-05 2005-01-06 Merck & Co., Inc. Substituted indoles and a process for preparing substituted indoles
CN109096293A (en) * 2018-08-28 2018-12-28 中节能万润股份有限公司 Preparation method of the one kind containing the benzofuran simultaneously alcohol compound of [2,3-b] pyridine structure
CN110964007A (en) * 2018-09-30 2020-04-07 江苏三月光电科技有限公司 Compound with quinolinone derivative as core and application of compound in organic electroluminescent device
CN111303171A (en) * 2020-03-27 2020-06-19 华中科技大学 A kind of benzofuranoindole compound, its preparation and application

Non-Patent Citations (10)

* Cited by examiner, † Cited by third party
Title
CARRIL, MONICA: "Recyclable copper-catalyst in aqueous media. O- and N-arylation reactions towards the benzofuroindole framework" *
CHAISAN, NATTAWADEE: "Dibrominative Spirocyclization of 2-Butynolyl Anilides: Synthesis of gem-Dibromospirocyclic Benzo[d][1,3]oxazines and Their Application in the Synthesis of 4H-Furo[3,2-b]indoles" *
DAWOOD, DAWOOD HOSNI: "Palladium-mediated domino oxidative amination of cyclohexadienes as an entry to indole alkaloids" *
DHARA, SHUBHENDU: "Synthesis of α, β and γ-carbolines via Pd-mediated Csp2-H/N-H activation" *
KALADEVI, SELVAM: "Cascade Rh(II) and Yb(III) catalyzed synthesis of substituted naphthofurans via transannulation of N-sulfonyl-1,2,3-triazoles with β-naphthols" *
PIROVANO, VALENTINA: "Gold-Catalyzed Cascade Reactions of 4H-Furo[3,2-b]indoles with Allenamides: Synthesis of Indolin-3-one Derivatives" *
PIROVANO, VALENTINA: "TI Synthesis of 2-alkenylidene-3-oxoindolines: cascade reactions of 4H-furo[3,2-b]indoles with diazoacetates catalyzed by a Cu(I) macrocyclic pyridine-containing ligand (PcL) complex" *
REDDY, K. RANJITH: "Palladium-Catalyzed Chemoselective Switch: Synthesis of a New Class of Indenochromenes and Pyrano[2,3-c]carbazoles" *
TSANG, W. C. PETER: "Palladium-catalyzed method for the synthesis of carbazoles via tandem C-H functionalization and C-N bond formation" *
YOUN, SO WON: "Pd-Catalyzed Intramolecular Oxidative C-H Amination: Synthesis of Carbazoles" *

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN115124535A (en) * 2022-06-16 2022-09-30 中南民族大学 A kind of fused ring indole compound and its preparation method and application
CN115124535B (en) * 2022-06-16 2024-02-27 中南民族大学 Condensed ring indole compound and preparation method and application thereof

Similar Documents

Publication Publication Date Title
CN102311434B (en) Evodiamine compounds, preparation method thereof and application thereof
Cheng et al. Intramolecular cross dehydrogenative coupling of 4-substituted coumarins: rapid and efficient access to coumestans and indole [3, 2-c] coumarins
CN103992336B (en) Oxa-or thia evodiamine anti-tumor derivant and preparation method thereof
CN110437238B (en) Polycyclic spiroindoline compound and preparation method and application thereof
CN107235992B (en) Indolinone spirotetrahydrothiophene compound and its salt, preparation method and application
CN114736212A (en) A kind of furo[3,2-b]indole derivative and its synthesis method and application
CN104744379B (en) A kind of quianzolinones and its synthetic method
Shaikh et al. Synthesis and biological evaluation of novel carbazole hybrids as promising antimicrobial agents
CN114716438B (en) Derivatives with benzo[7,8]indazine[1,2-c]quinoline skeleton and synthesis method thereof
Yan et al. Catalyst-free synthesis of alkyl 4-oxo-4H-pyrido [1, 2-a] pyrimidine-2-carboxylate derivatives on water
Sołoducho New route to the synthesis of the indolo [7, 6-g] indole (“bis (pyrrolo) naphthalene”) system starting from 1, 5-dihydroxynaphthalene
Carullo et al. Green Synthesis of New Pyrrolo [1, 2‐a] quinoxalines as Antiproliferative Agents in GPER‐expressing Breast Cancer Cells
Dong et al. Short and efficient synthesis of Guillou's Galanthamine intermediate
CN108997197B (en) A kind of cyanocarbazole derivatives and synthetic method thereof
CN112979529B (en) Aromatic amine indole naphthoquinone derivative and preparation method thereof
CN101747255B (en) Isoindolinone compound containing enyne structure and its synthesis method
Li et al. Simple and efficient one-pot multi-step strategy for the synthesis of 2-substituted (1, 2, 5-triarylpyrrolo [3, 2-c] pyridin-3-yl)-N-arylacetamide derivatives in water
CN116102552B (en) Quinoline-2,3-fused nine-membered ring skeleton compound, preparation method and application thereof
Surya Prakash Rao et al. Palladium-catalyzed intramolecular C–N coupling: Facile synthesis of tetracyclic C (3)-aminoisoindolinones
Ajay et al. Rh (III)‐Catalyzed Sequential ortho‐C‐H Bond Annulation and Desulfonylation of 3‐Aryl‐2H‐benzo [e][1, 2, 4] thiadiazine‐1, 1‐dioxides: Access to 1‐Aminoisoquinolines
CN109456155A (en) A method of tetralin ketone derivatives quickly being prepared based on substitution cyclobutanol oxidation open loop/cyclization
Bui et al. Solvent-free strategy for facile synthesis and cytotoxicity evaluation of benzimidazole derivatives
CN112300181B (en) Diketone skeleton compound and preparation method and application thereof
CN110105364B (en) N-p-chlorophenyl substituted maleimide α-terpinene cycloaddition derivatives containing pyrazole structure and preparation method and application thereof
CN108997196A (en) A kind of carbazole analog derivative and its synthetic method

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
RJ01 Rejection of invention patent application after publication

Application publication date: 20220712

RJ01 Rejection of invention patent application after publication